Summary T1DM neuropathy and T2DM neuropathy are fundamentally different. In T1DM,
glucose control has a large effect on the prevention of neuropathy; therefore, future efforts …

In the USA diabetes mellitus affects over 16 million people, and the number of diabetic
persons is increasing by an estimated 5% per year [1]. Diabetic neuropathy is a common …

The global epidemic of prediabetes and diabetes has led to a corresponding epidemic of
complications of these disorders. The most prevalent complication is neuropathy, of which …

Diabetes is the leading cause of peripheral neuropathy globally. Duration of diabetes,
glycemic control, and preexisting cardiovascular risk factors independently correlate with the …

In this article we describe differences in early metabolic abnormalities between type 1 and
type 2 diabetic polyneuropathy (DPN), and how these differences lead to milder initial …

An increasing understanding of the pathogenetic mechanisms holds out promise for the
effective treatment of diabetic neuropathy. The early detection of abnormal glucose …

Abstract Purpose of Review: This article provides an overview for understanding the
diagnosis, pathogenesis, and management of diabetic neuropathy. Recent Findings: New …

Diabetic neuropathies (DNs) differ in clinical course, distribution, fiber involvement (type and
size), and pathophysiology, the most typical type being a length-dependent distal symmetric …

Neuropathies related to diabetes mellitus can affect 60–70% of patients with diabetes.
These can include peripheral polyneuropathies, mononeuropathies, and autonomic …

The incidence of diabetes is increasing at epidemic rates. There currently are an estimated
17 million individuals with diabetes in the United States and this number is rapidly …